1.38
0.07 (5.34%)
Penutupan Terdahulu | 1.31 |
Buka | 1.30 |
Jumlah Dagangan | 39,425 |
Purata Dagangan (3B) | 114,508 |
Modal Pasaran | 51,601,096 |
Harga / Jualan (P/S) | 1.08 |
Harga / Buku (P/B) | 1.70 |
Julat 52 Minggu | |
Tarikh Pendapatan | 14 May 2025 - 19 May 2025 |
Margin Keuntungan | -29.66% |
Margin Operasi (TTM) | -18.40% |
EPS Cair (TTM) | -0.580 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 3.60% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 34.17% |
Nisbah Semasa (MRQ) | 1.85 |
Aliran Tunai Operasi (OCF TTM) | -13.58 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -10.75 M |
Pulangan Atas Aset (ROA TTM) | -14.45% |
Pulangan Atas Ekuiti (ROE TTM) | -38.88% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Distribution (US) | Bercampur | Menurun |
Medical Distribution (Global) | Bercampur | Menurun | |
Stok | EDAP TMS S.A. | Menurun | Menurun |
AISkor Stockmoo
Konsensus Penganalisis | 1.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 0.5 |
Purata Bergerak Teknikal | -2.5 |
Osilator Teknikal | -2.5 |
Purata | -0.88 |
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others. |
|
Sektor | Healthcare |
Industri | Medical Distribution |
Gaya Pelaburan | Small Value |
% Dimiliki oleh Institusi | 41.12% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Bruce & Co., Inc. | 31 Dec 2024 | 553,652 |
Cahill Financial Advisors Inc | 31 Dec 2024 | 134,960 |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 19.00 (HC Wainwright & Co., 1,276.81%) | Beli |
Median | 4.50 (226.09%) | |
Rendah | 2.00 (Jefferies, 44.93%) | Pegang |
Purata | 8.50 (515.94%) | |
Jumlah | 2 Beli, 1 Pegang | |
Harga Purata @ Panggilan | 1.97 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Jefferies | 04 Apr 2025 | 2.00 (44.93%) | Pegang | 1.61 |
HC Wainwright & Co. | 28 Mar 2025 | 19.00 (1,276.81%) | Beli | 2.15 |
Piper Sandler | 28 Mar 2025 | 4.50 (226.09%) | Beli | 2.15 |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
15 May 2025 | Pengumuman | EDAP Reports First Quarter 2025 Financial Results |
01 May 2025 | Pengumuman | EDAP to Announce First Quarter 2025 Financial Results on May 15, 2025 |
29 Apr 2025 | Pengumuman | EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting |
24 Apr 2025 | Pengumuman | EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting |
22 Apr 2025 | Pengumuman | EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting |
27 Mar 2025 | Pengumuman | EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results |
06 Mar 2025 | Pengumuman | EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 |
03 Mar 2025 | Pengumuman | EDAP Appoints Glen French to Board of Directors |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |